Neil E. Caporaso mainly focuses on Internal medicine, Lung cancer, Genetics, Oncology and Cancer. His study in Internal medicine is interdisciplinary in nature, drawing from both Endocrinology, Immunology, Pathology, Allele and Genotype. His work deals with themes such as Odds ratio, Case-control study, Lung, Lung cancer susceptibility and Adenocarcinoma, which intersect with Lung cancer.
His study explores the link between Odds ratio and topics such as Confidence interval that cross with problems in Physiology. Neil E. Caporaso combines subjects such as Relative risk, Gynecology, Proportional hazards model and Mass screening with his study of Oncology. The Cancer study combines topics in areas such as Gene expression profiling, Lymphoma and Risk factor.
His scientific interests lie mostly in Internal medicine, Lung cancer, Cancer, Genetics and Oncology. His Internal medicine research incorporates elements of Endocrinology, Immunology, Genotype and Pathology. His Lung cancer research is multidisciplinary, relying on both Odds ratio, Genome-wide association study, Single-nucleotide polymorphism, Case-control study and Adenocarcinoma.
As part of one scientific family, Neil E. Caporaso deals mainly with the area of Genome-wide association study, narrowing it down to issues related to the Genetic association, and often Computational biology. In his research on the topic of Cancer, Proportional hazards model is strongly related with Hazard ratio. His Oncology research includes themes of Prospective cohort study, Lung and Cohort.
Neil E. Caporaso mainly investigates Lung cancer, Internal medicine, Genome-wide association study, Oncology and Cancer. His Lung cancer study incorporates themes from Odds ratio, Genetics, Case-control study, Single-nucleotide polymorphism and Adenocarcinoma. His research on Internal medicine often connects related areas such as Endocrinology.
He works mostly in the field of Genome-wide association study, limiting it down to concerns involving Genetic association and, occasionally, Computational biology. His work in Oncology addresses subjects such as Confounding, which are connected to disciplines such as Chronic lymphocytic leukemia. Neil E. Caporaso focuses mostly in the field of Cancer, narrowing it down to topics relating to Epidemiology and, in certain cases, Public health and Gerontology.
Neil E. Caporaso mostly deals with Lung cancer, Internal medicine, Odds ratio, Cohort and Case-control study. His work carried out in the field of Lung cancer brings together such families of science as Carcinogenesis, Genome-wide association study and Adenocarcinoma. His Genome-wide association study study improves the overall literature in Genetics.
The various areas that Neil E. Caporaso examines in his Internal medicine study include Endocrinology and Oncology. His Odds ratio research includes elements of Single-nucleotide polymorphism, Allele frequency and Confidence interval. Case-control study is the subject of his research, which falls under Pathology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: A prospective study
Ola Landgren;Robert A. Kyle;Ruth M. Pfeiffer;Jerry A. Katzmann.
The national lung screening trial: Overview and study design
Constantine A. Gatsonis;Denise R. Aberle;Christine D. Berg;William C. Black.
Genome-partitioning of genetic variation for complex traits using common SNPs
Jian Yang;Teri A. Manolio;Louis R. Pasquale;Eric Boerwinkle.
Nature Genetics (2011)
Population Stratification in Epidemiologic Studies of Common Genetic Variants and Cancer: Quantification of Bias
Sholom Wacholder;Nathaniel Rothman;Neil Caporaso.
Journal of the National Cancer Institute (2000)
Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival.
Maria Teresa Landi;Tatiana Dracheva;Melissa Rotunno;Jonine D. Figueroa.
PLOS ONE (2008)
Selection criteria for lung-cancer screening.
Martin C. Tammemägi;Hormuzd A. Katki;William G. Hocking;Timothy R. Church.
The New England Journal of Medicine (2013)
Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites.
M A Butler;N P Lang;J F Young;N E Caporaso.
Tumor Immunobiological Differences in Prostate Cancer between African-American and European-American Men
Tiffany A. Wallace;Robyn L. Prueitt;Ming Yi;Tiffany M. Howe.
Cancer Research (2008)
A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for Adenocarcinoma.
Maria Teresa Landi;Nilanjan Chatterjee;Kai Yu;Lynn R. Goldin.
American Journal of Human Genetics (2009)
Detectable clonal mosaicism and its relationship to aging and cancer
Kevin B. Jacobs;Kevin B. Jacobs;Meredith Yeager;Meredith Yeager;Weiyin Zhou;Weiyin Zhou;Sholom Wacholder.
Nature Genetics (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: